BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 7966432)

  • 1. Hypertension-related coronary thrombosis: prothrombic role of angiotensin II.
    Spillert CR; Sun S; Miller MA; Lazaro EJ
    J Natl Med Assoc; 1994 Sep; 86(9):686-8. PubMed ID: 7966432
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Are hypertensives hypercoagulable?
    Miller MA; Spillert CR; Ponnudurai R; Bonthu S; Lazaro EJ
    J Natl Med Assoc; 1995 Jan; 87(1):71-2. PubMed ID: 7869410
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modified recalcification time: a global coagulation screening test.
    Spillert CR; Lazaro EJ
    J Natl Med Assoc; 1993 Aug; 85(8):611-6. PubMed ID: 8371283
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deceptive prothrombin and activated partial thromboplastin times in alcoholic cirrhosis.
    Sirikonda PR; Spillert CR; Koneru B; Ponnudurai R; Wilson DJ; Lazaro EJ
    J Natl Med Assoc; 1996 May; 88(5):306-9. PubMed ID: 8667440
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modified recalcification time (MRT): a sensitive cancer test? Review of the evidence.
    Spillert CR; Lazaro EJ
    J Natl Med Assoc; 1995 Sep; 87(9):687-92. PubMed ID: 9583965
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor necrosis factor-induced necrosis: a monocyte-mediated hypercoagulable effect.
    Spillert CR; Sun S; Ponnudurai R; Miller MA; Lazaro EJ
    J Natl Med Assoc; 1995 Jul; 87(7):508-9. PubMed ID: 7636898
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of platelet age in assessment of coagulation.
    Spillert CR; Lee CS; Federici EE; Lazaro EJ
    J Natl Med Assoc; 1995 Dec; 87(12):869-71. PubMed ID: 8558618
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prothrombotic effects of endothelin-2 (ET-2).
    Raff GW; Spillert CR; Wilson DJ; Lazaro EJ
    Agents Actions; 1993; 39 Spec No():C104-5. PubMed ID: 8273542
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypercoagulability in arterial disease.
    Spillert CR; Milazzo VJ; Suval WD; Lazaro EJ
    Angiology; 1989 Oct; 40(10):886-9. PubMed ID: 2802258
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiotensin II via AT1 receptor accelerates arterial thrombosis in renovascular hypertensive rats.
    Kamińska M; Mogielnicki A; Stankiewicz A; Kramkowski K; Domaniewski T; Buczko W; Chabielska E
    J Physiol Pharmacol; 2005 Dec; 56(4):571-85. PubMed ID: 16391415
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prediction of clinical course in diabetes using a simple coagulation test.
    Spillert CR; Milazzo VJ; Pastena JA; Lazaro EJ
    J Natl Med Assoc; 1989 Jan; 81(1):81-3. PubMed ID: 2724359
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiotensin II, tissue factor and the thrombotic paradox of hypertension.
    Celi A; Cianchetti S; Dell'Omo G; Pedrinelli R
    Expert Rev Cardiovasc Ther; 2010 Dec; 8(12):1723-9. PubMed ID: 21108554
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vascular smooth muscle cell NAD(P)H oxidase activity during the development of hypertension: Effect of angiotensin II and role of insulinlike growth factor-1 receptor transactivation.
    Cruzado MC; Risler NR; Miatello RM; Yao G; Schiffrin EL; Touyz RM
    Am J Hypertens; 2005 Jan; 18(1):81-7. PubMed ID: 15691621
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Natural history of hypercoagulability in patients undergoing coronary revascularization and effect of preoperative myocardial infarction.
    Edelman JJ; Reddel CJ; Kritharides L; Bannon PG; Fraser JF; Curnow JL; Vallely MP
    J Thorac Cardiovasc Surg; 2014 Aug; 148(2):536-43. PubMed ID: 24280714
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiotensin II induces the expression of tissue factor and its mechanism in human monocytes.
    He M; He X; Xie Q; Chen F; He S
    Thromb Res; 2006; 117(5):579-90. PubMed ID: 15953627
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiotensin II increases human monocyte matrix metalloproteinase-1 through the AT2 receptor and prostaglandin E2: implications for atherosclerotic plaque rupture.
    Kim MP; Zhou M; Wahl LM
    J Leukoc Biol; 2005 Jul; 78(1):195-201. PubMed ID: 15817699
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contribution of the monocyte to thrombotic potential.
    Spillert CR; Lazaro EJ
    Agents Actions; 1991 Sep; 34(1-2):28-9. PubMed ID: 1793044
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of methylprednisolone on coagulation.
    Pandit HB; Spillert CR
    J Natl Med Assoc; 1999 Aug; 91(8):453-6. PubMed ID: 12656434
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insertion/deletion polymorphism in the angiotensin-converting enzyme gene and risk of and prognosis after myocardial infarction.
    Samani NJ; O'Toole L; Martin D; Rai H; Fletcher S; Lodwick D; Thompson JR; Morice AH; Channer K; Woods KL
    J Am Coll Cardiol; 1996 Aug; 28(2):338-44. PubMed ID: 8800107
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of angiotensin II blockade on cardiac hypertrophy and remodelling: a review.
    Dahlöf B
    J Hum Hypertens; 1995 Nov; 9 Suppl 5():S37-44. PubMed ID: 8583480
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.